High-risk human papillomavirus DNA testing: A marker for atypical glandular cells

Diagnostic Cytopathology

Volumn 34, Issue 3, 2006, Pages 235-239

  Saqi, Anjali ^a,c   Gupta, Prabodh K ^b   Erroll, Maria ^c   Babiac, Anamaria ^a   Blackmun, Dorothy ^d   Mansukhani, Mahesh ^a   Vazquez, Madeline ^c  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d LENOX HILL HOSPITAL   (United States)

Author keywords

Atypical glandular cells; HPV; Hybrid Capture 2; Pap smear; ThinPrep

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER INCIDENCE; DIAGNOSTIC ACCURACY; FEMALE; FEMALE GENITAL TRACT INFECTION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; CERVIX UTERI; DNA PROBES, HPV; DNA, VIRAL; FEMALE; GENETIC MARKERS; HUMANS; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33644890167     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20369     Document Type: Article

References (33)

1. Davey D. Cervical cancer screening: will human papillomavirus testing replace cytology? J Low Genit Tract Dis 2004;8:6-9.
2. Sherman ME, Wang SS, Carreon J, Devesa SS. Mortality trends for cervical squamous and adenocarcinoma in the United States. Cancer 2005;103:1258-1264.
3. Lee KR. Adenocarcinoma in situ with a small cell (endometrioid) pattern in cervical smears: a test of the distinction from benign mimics using specific criteria. Cancer 1999;87:254-258.
4. Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423-428.
5. Stockton D, Cooper P, Lonsdale RN. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen 1997;4:40-43.
6. Zheng T, Holford TR, Ma Z, et al. The continuing increase in adenocarcinoma of the uterine cervix: a birth cohort phenomenon. Int J Epidemiol 1996;25:252-258.
7. Smotkin D, Berek JS, Fu YS, Hacker NF, Major FJ, Wettstein FO. Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol 1986;68:241-244.
8. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol 2000;157:1055-1062.
9. Ronnett BM, Manos MM, Ransley JE, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999;30:816-825.
10. Levine L, Lucci JA, III, Dinh TV. Atypical glandular cells: new Bethesda terminology and management guidelines. Obstet Gynecol Surv 2003;58:399-406.
11. Siziopikou KP, Wang HH, Abu-Jawdeh G. Cytologic features of neoplastic lesions in endocervical glands. Diagn Cytopathol 1997;17:1-7.
12. Wright TC, Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
13. Krane JF, Lee KR, Sun D, Yuan L, Crum CP. Atypical glandular cells of undetermined significance. Outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004;121:87-92.
14. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer Verlag; 1994.
15. Nasuti JF, Fleisher SR, Gupta PK. Atypical glandular cells of undetermined significance (AGUS): clinical considerations and cytohistologic correlation. Diagn Cytopathol 2002;26:186-190.
16. Kim TJ, Kim HS, Park CT, et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:292-298.
17. Valente PT, Schantz HD, Schultz M. Cytologic atypia associated with microglandular hyperplasia. Diagn Cytopathol 1994;10:326-331.
18. Pacey F, Ayer B, Greenberg M. The cytologic diagnosis of adenocarcinoma in situ of the cervix uteri and related lesions. III. Pitfalls in diagnosis. Acta Cytol 1988;32:325-330.
19. Novotny DB, Maygarden SJ, Johnson DE, Frable WJ. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 1992;36:1-10.
20. Ducatman BS, Wang HH, Jonasson JG, Hogan CL, Antonioli DA. Tubal metaplasia: a cytologic study with comparison to other neoplastic and non-neoplastic conditions of the endocervix. Diagn Cytopathol 1993;9:98-103; discussion 103-105.
21. de Peralta-Venturino MN, Purslow MJ, Kini SR. Endometrial cells of the "lower uterine segment"(LUS) in cervical smears obtained by endocervical brushings: a source of potential diagnostic pitfall. Diagn Cytopathol 1995;12:263-268; discussion 268-271.
22. Burja IT, Thompson SK, Sawyer WL, Jr., Shurbaji MS. Atypical glandular cells of undetermined significance on cervical smears. A study with cytohistologic correlation. Acta Cytol 1999;43:351-356.
23. Lee KR, Darragh TM, Joste NE, Krane JF, Sherman ME, Hurley LB, Allred EM, Manos MM. Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol 2002;117:96-102.
24. Oliveira ER, Derchain SF, Rabelo-Santos SH, et al. Detection of high-risk human papillomavirus (HPV) DNA by Hybrid Capture II in women referred due to atypical glandular cells in the primary screening. Diagn Cytopathol 2004;31:19-22.
25. Eddy GL, Strumpf KB, Wojtowycz MA, Piraino PS, Mazur MT. Biopsy findings in five hundred thirty-one patients with atypical glandular cells of uncertain significance as defined by the Bethesda system. Am J Obstet Gynecol 1997;177:1188-1195.
26. Soofer SB, Sidawy MK. Atypical glandular cells of undetermined significance: clinically significant lesions and means of patient follow-up. Cancer 2000;90:207-214.
27. Selvaggi SM. Please! No "AGUS" swamp. Atypical glandular cells of undetermined significance. Diagn Cytopathol 1999;21:157-158.
28. Selvaggi SM. Cytologic features of squamous cell carcinoma in situ involving endocervical glands in endocervical cytobrush specimens. Acta Cytol 1994;38:687-692.
29. Selvaggi SM. Cytologic features of high-grade squamous intraepithelial lesions involving endocervical glands on thinprep cytology. Diagn Cytopathol 2002;26:181-185.
30. Cheng RF, Hernandez E, Anderson LL, Heller PB, Shank R. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance. J Reprod Med 1999;44:922-928.
31. Obenson K, Abreo F, Grafton WD. Cytohistologic correlation between AGUS and biopsy-detected lesions in postmenopausal women. Acta Cytol 2000;44:41-45.
32. Zweitig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314-318.
33. Derchain SF, Rabelo-Santos SH, Sarian LO, et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004;95:618-623.